BetaAbout 1.4% of the shares they held or received (after tax withholding) during the period. The usual measure, against starting holdings alone, can't be used here because most of the shares sold arrived during the period.
No officer or director trades were reported for the past 30 days. The most recent before that:
| Who | Shares | Price | % of total stake | Total stake after | Trade date | Filed |
|---|---|---|---|---|---|---|
| Craig Slavtcheff Chief R&D Officer | 2,245 | $109.31 | 25% | 6.7K | Jul 31, 2026 | Aug 4, 2026 |
| Patricia Corsi Chief Growth Officer | 404 | $109.31 | 20% | 1.7K | Jul 31, 2026 | Aug 4, 2026 |
"% of total stake" is the shares in this event against all the vested shares the person held that day, across every share class and holding entity, after that day's vesting. "n/a" means the person's holdings don't reconcile, or the row is a purchase. "Holdings record incomplete" means more shares were sold than the filings show the person held that day, so a percentage would be wrong.
Percentages cover 18 of 30 officers and directors. 12 are left out Disclosed company stock is not an insider's whole wealth.i
Left out: Mae Jemison, Christa Quarles, Sherilyn McCoy, Jaime Ramirez, Sylvia Burwell, Deeptha Khanna, Joseph Romanelli, Stacey Panayiotou and John Carmichael (held no vested shares at the start); Dunia Shive (most holdings were last confirmed in 2019); John Culver (most holdings were last confirmed in 2020); Deirdre Mahlan (most holdings were last confirmed in 2021).
Officers and directors, past 12 months. Each bar is 100% of that person's own stake; not comparable between people. The stake is the vested shares held at the start of the period (Oct 9, 2025); the gold part is what they sold.
Officers and directors, Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
No. Michael Hsu reported no open-market sales in the past 12 months.
Filings rarely give a reason, and we don't guess at one. What they show is how the sales were made: 0% of sales by value ran under 10b5-1 trading plans disclosed in the filings, 29% were to cover taxes and 71% had no disclosed plan. A trading plan schedules sales in advance.
Yes. 1 officer or director reported 1 purchase in the past 12 months (Form 4 code P, which includes private purchases).
About 1.4% of the shares they held or received (after tax withholding) during the period. The usual measure, against starting holdings alone, can't be used here because most of the shares sold arrived during the period. That covers the 12 months to Oct 9, 2026 and counts vested shares reported on SEC Forms 3, 4 and 5, which is not an insider's whole wealth.
| Who sold | Amount | % of holdings | Trading plan |
|---|---|---|---|
| Andrew Scribner Controller, VP & FP&A | $719K 7.1K shares | 100%†i† Most of the shares Andrew Scribner sold arrived during the period, so this is shares sold as a share of the 3K held at the start plus the 5.4K received, less 1.3K withheld by the company for taxes. | No plan disclosed |
| Katy Chen President, Int'l Personal Care | $288K 3K shares | 26%†i† Most of the shares Katy Chen sold arrived during the period, so this is shares sold as a share of the 4K held at the start plus the 7.4K received, less 0 withheld by the company for taxes. | To cover taxes |
Vested shares across all share classes, held directly and through trusts, LLCs and family members, as reported on SEC Forms 3, 4 and 5. Unvested awards and options are never counted as owned shares.
| Insider | Held Oct 9, 2025 | Sold | Held Oct 9, 2026 | Still held |
|---|---|---|---|---|
Michael HsuiIncludes unvested RSUs, amount not disclosed. Chairman of the Board and CEO, Director | 287K | 0 | 355K | no sales |
Vesting, gifts, unvested awards and holding lines for Michael Hsu+35Kshares vested or exercised 0gifted (net of own trusts) −44Kwithheld by the company for taxes 126K → 215Kunvested awards, start → end
| ||||
Russell TorresiIncludes unvested RSUs, amount not disclosed. President and COO | 67K | 0 | 86K | no sales |
Vesting, gifts, unvested awards and holding lines for Russell Torres | ||||
Jeffrey MelucciiIncludes unvested RSUs, amount not disclosed. Chief Bus., Strat. & Admin. | 47K | 0 | 64K | no sales |
Vesting, gifts, unvested awards and holding lines for Jeffrey Melucci | ||||
Ehab Abou-OafiIncludes unvested RSUs, amount not disclosed. Pres. Int'l Fam. Care & Prof. | 41K | 0 | 55K | no sales |
Vesting, gifts, unvested awards and holding lines for Ehab Abou-Oaf | ||||
Nelson UrdanetaiIncludes unvested RSUs, amount not disclosed. Chief Financial Officer | 28K | 0 | 45K | no sales |
Vesting, gifts, unvested awards and holding lines for Nelson Urdaneta | ||||
Sandra KarrmanniIncludes unvested RSUs, amount not disclosed. Chief People Officer | 25K | 0 | 25K | no sales |
Vesting, gifts, unvested awards and holding lines for Sandra Karrmann | ||||
Zackery HicksiIncludes unvested RSUs, amount not disclosed. Chief Digital & Technology Off | 14K | 0 | 14K | no sales |
Vesting, gifts, unvested awards and holding lines for Zackery Hicks | ||||
Andrew DrexleriIncludes unvested RSUs, amount not disclosed. Vice President and Controller | 9.2K | 0 | 9.2K | no sales |
Vesting, gifts, unvested awards and holding lines for Andrew Drexler | ||||
Suzana BladesiStarted reporting during the period; starting holdings are from the Form 3. SVP and General Counsel | 6.7K | 0 | 6.7K | no sales |
Vesting, gifts, unvested awards and holding lines for Suzana Blades | ||||
Tamera FenskeiIncludes unvested RSUs, amount not disclosed. Chief Supply Chain Officer | 6.2K | 0 | 30K | no sales |
Vesting, gifts, unvested awards and holding lines for Tamera Fenske | ||||
Katy CheniIncludes unvested RSUs, amount not disclosed. President, Int'l Personal Care | 4K | −3K | 8.4K | not meaningful |
Vesting, gifts, unvested awards and holding lines for Katy Chen | ||||
Andrew ScribneriIncludes unvested RSUs, amount not disclosed. Controller, VP & FP&A | 3K | −7.1K | 0 | not meaningful |
Vesting, gifts, unvested awards and holding lines for Andrew Scribner | ||||
Craig SlavtcheffiIncludes unvested RSUs, amount not disclosed. Chief R&D Officer | 2.9K | 0 | 6.7K | no sales |
Vesting, gifts, unvested awards and holding lines for Craig Slavtcheff | ||||
Grant McGeeiIncludes unvested RSUs, amount not disclosed. General Counsel & Secretary | 2.7K | 0 | 6.1K | no sales |
Vesting, gifts, unvested awards and holding lines for Grant McGee | ||||
| Todd Maclin Director | 2.4K | 0 | 12K | no sales |
| Mark Smucker Director | 827 | 0 | 827 | no sales |
Patricia CorsiiIncludes unvested RSUs, amount not disclosed. Chief Growth Officer | 536 | 0 | 1.7K | no sales |
Vesting, gifts, unvested awards and holding lines for Patricia Corsi | ||||
Francesco TintoiStarted reporting during the period; starting holdings are from the Form 3. Chief Info & GBS Officer | 45 | 0 | 45 | no sales |
Vesting, gifts, unvested awards and holding lines for Francesco Tinto | ||||
30 of 30 insiders fully reconciled: starting holdings plus reported transactions match ending holdings (30 exactly, 0 with a minor or footnoted difference). Percentages cover 18 of 30 officers and directors. Left out: Mae Jemison, Christa Quarles, Sherilyn McCoy, Jaime Ramirez, Sylvia Burwell, Deeptha Khanna, Joseph Romanelli, Stacey Panayiotou and John Carmichael (held no vested shares at the start); Dunia Shive (most holdings were last confirmed in 2019); John Culver (most holdings were last confirmed in 2020); Deirdre Mahlan (most holdings were last confirmed in 2021). "Still held" compares ending with starting vested shares; a plus sign means the holding grew.
Officer and director open-market sales: $1.0M across 10,145 shares. Plan status and stated purpose are separate questions, and a sale can have both.
Sales with no 10b5-1 plan and no tax reference in the filing. $719K of it is Andrew Scribner. No plan disclosed is a statement about the filing, not about why the sale happened. Largest such sale: Andrew Scribner, May 6, 2026
$288K of sales (28.6%) cite tax obligations in their footnotes. Separately, 105,615 shares ($10.6M) were withheld by the company for taxes, which isn't a market sale. Example: Katy Chen, May 4, 2026
1 officer or director bought shares in this period, in 1 trade(Form 4 code P). Across all their filings on record there are 7 purchase trades.
| Seller | Shares sold | Proceeds | Under a disclosed plan | Share of total | Sales dates |
|---|---|---|---|---|---|
| Andrew Scribner Controller, VP & FP&A | 7.1K | $719K | 0% | 71% | Feb 5, 2026 to May 6, 2026 |
| Katy Chen President, Int'l Personal Care | 3K | $288K | 0% | 29% | Apr 30, 2026 to May 4, 2026 |
| Month | Sale proceeds | Disclosed plan | To cover taxes | No plan disclosed |
|---|---|---|---|---|
| Oct 2025 | $0 | $0 | $0 | $0 |
| Nov 2025 | $0 | $0 | $0 | $0 |
| Dec 2025 | $0 | $0 | $0 | $0 |
| Jan 2026 | $0 | $0 | $0 | $0 |
| Feb 2026 | $318K | $0 | $0 | $318K |
| Mar 2026 | $0 | $0 | $0 | $0 |
| Apr 2026 | $136K | $0 | $136K | $0 |
| May 2026 | $553K | $0 | $152K | $401K |
| Jun 2026 | $0 | $0 | $0 | $0 |
| Jul 2026 | $0 | $0 | $0 | $0 |
| Aug 2026 | $0 | $0 | $0 | $0 |
| Sep 2026 | $0 | $0 | $0 | $0 |
| Oct 2026 | $0 | $0 | $0 | $0 |
Less than usual: about one-eighth of the 5-year average. 2 insiders sold; the average is 5 a year.
| 12 months ending | Shares sold | Insiders who sold | Proceeds |
|---|---|---|---|
| Oct 9, 2026 Latest 12 months | 10K | 2 | $1.0M |
| Oct 9, 2025 1 year earlier | 34K | 3 | $4.6M |
| Oct 9, 2024 2 years earlier | 161K | 11 | $21.9M |
| Oct 10, 2023 3 years earlier | 69K | 6 | $9.8M |
| Oct 10, 2022 4 years earlier | 94K | 4 | $13.0M |
| Oct 10, 2021 5 years earlier | 50K | 3 | $6.9M |
Open-market sales (Form 4 code S) by people who were officers or directors, in split-adjusted shares. Earlier years include people who have since left. A sale that an outside holder also reports (a family trust, a fund) is counted with outside holders in every year. Shares, not dollars, are compared, so a change in the stock price doesn't look like a change in selling. Years the filings don't fully cover are shown but left out of the average.
Every officer and director reconciles for this period.
Inferred rename: "Incentive Investment Plan" is treated as the same holder as "401(k) and Profit Sharing Plan", because the old name was never reported again and the new one opened with the same balance (117 shares). Old name, new name
External context: we only cite outside events when a documented connection exists. None is shown for this period.
All 2,133 Forms 3, 4 and 5 filed for Kimberly-Clark (SEC CIK 55785) from May 8, 2003 to Sep 1, 2026, retrieved from SEC EDGAR on Oct 9, 2026. Prices are the ones reported in each filing, often weighted averages. 4 filings were left out because Kimberly-Clark filed them as an owner of another company's stock.
Holdings. Each holding line (a share class plus an owner, such as a trust or LLC) carries its last reported balance forward. Entities first reported during the period start at zero, so transfers between an insider's own trusts don't count as selling. Lines not reported for three years or more are listed separately and left out of totals.
Sales. A sale counts as under a 10b5-1 plan if its footnote cites one or the filing's Rule 10b5-1 box is checked, and as tax-related if its footnote cites tax obligations or sell-to-cover. Shares withheld by the company for taxes are listed separately. Sales with neither attribute are labeled "no plan disclosed".
Spotted something wrong on this page? Report an error. We check every report against the SEC filing and list what we fix in the corrections log.